Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107
| Conditions: | Malignant Mesothelioma |
| Start Date: | |
| Phase: | |
| Status: | Active, not recruiting |
| NCT ID: | NCT00898547 |
| Study Type: | Observational |
| Intervention: | Other: immunoenzyme technique|Other: laboratory biomarker analysis |
| Study Design: | |
| Results: | No Results Available |
| Sponsors: | Cancer and Leukemia Group B|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 47 |
| Funded By: | Other|NIH |
| First Received: | May 9, 2009 |
| End Date: | |
| Last Updated: | May 16, 2009 |
| Last Verified: | November 1, 2006 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
